Etiology of pruritic papular eruption with HIV infection in Uganda

被引:43
作者
Resneck, JS
Van Beek, M
Furmanski, L
Oyugi, J
LeBoit, PE
Katabira, E
Kambugu, F
Maurer, T
Berger, T
Pletcher, MJ
Machtinger, EL
机构
[1] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[6] Univ Iowa, Dept Dermatol, Iowa City, IA USA
[7] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[8] Reach Out Mbuya Parish AIDS Initiat, Kampala, Uganda
[9] Acad Alliance AIDS Care & Prevent Africa, Kampala, Uganda
[10] Makerere Univ, Kampala, Uganda
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 21期
关键词
D O I
10.1001/jama.292.21.2614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context A frequent cause of human immunodeficiency virus (HIV)-related morbidity in sub-Saharan Africa is a commonly occurring, intensely pruritic skin rash. The resulting scars are disfiguring and stigmatizing. Despite the substantial prevalence of pruritic papular eruption (PPE) among HIV-infected Africans, the cause has been elusive. Objective To determine the etiology of PPE occurring in HIV-infected individuals. Design, Setting, and Patients Cross-sectional study of HIV-infected patients with active PPE from clinics in Uganda conducted from May 19 through June 6, 2003. Enrollment occurred in the month preceding May 19. Each participant was clinically examined by 2 dermatologists, had laboratory studies performed, was administered an epidemiologic questionnaire, and had a skin biopsy of a new lesion evaluated by a dermatopathologist. Main Outcome Measures Histological characteristics of new pruritic lesions. Other assessments included CD4 cell count, eosinophil count, and physician-assessed rash severity. Results Of 109 patients meeting inclusion criteria, 102 (93.6%) completed the study. The CD4 cell counts in this study population were generally low (median, 46/muL) and inversely related to increasing rash severity (median CD4 cell counts: 122 for mild, 41 for moderate, and 9 for severe; P<.001 for trend). Eighty-six patients (84%; 95% confidence interval, 77%-91%) had biopsy findings characteristic of arthropod bites. Patients with arthropod bites on biopsy had significantly higher peripheral eosinophil counts (median, 330 vs 180/μL; P=.02) and had a trend toward lower CD4 cell counts (median, 40 vs 99/μL; P=.07) than those without histological evidence of arthropod bites. Conclusions Pruritic papular eruption occurring in HIV-infected individuals may be a reaction to arthropod bites. We hypothesize that this condition reflects an altered and exaggerated immune response to arthropod antigens in a subset of susceptible HIV-infected patients.
引用
收藏
页码:2614 / 2621
页数:8
相关论文
共 32 条
[1]  
ACKERMAN AB, 1997, HISTOLOGIC DIAGNOSIS, P202
[2]   Cytokines in the pruritic papular eruption of HIV [J].
Aires, JM ;
Rosatelli, JB ;
Figueiredo, JFD ;
Roselino, AMF .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (12) :903-906
[3]  
ALCOM K, 2004, AIDSMAP NEWS 0218
[4]   Increased proportions of activated and proliferating memory CD8+ T lymphocytes in both blood and lung are associated with blood HIV viral load [J].
Barry, SM ;
Johnson, MA ;
Janossy, G .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (04) :351-357
[5]   PRURITIC PAPULAR ERUPTION OF HIV-DISEASE [J].
BASON, MM ;
BERGER, TG ;
NESBITT, LT .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (11) :784-789
[6]   Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression [J].
Boonchai, W ;
Laohasrisakul, R ;
Manonukul, J ;
Kulthanan, K .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (05) :348-350
[7]   Molecular and cellular mechanisms of allergic disease [J].
Broide, DH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :S65-S71
[8]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[9]  
COLEBUNDERS R, 1987, AIDS, V1, P117
[10]  
ELGART ML, 1996, CUTANEOUS MED SURG I, P804